732 related articles for article (PubMed ID: 12684669)
41. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
42. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
43. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
[TBL] [Abstract][Full Text] [Related]
44. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
[TBL] [Abstract][Full Text] [Related]
45. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
46. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
[TBL] [Abstract][Full Text] [Related]
47. [Gastric cancer and microsatellite instability].
Itoh F; Yamamoto H; Horiuchi S; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2002 Sep; 99(9):1043-9. PubMed ID: 12355890
[No Abstract] [Full Text] [Related]
48. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
49. Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements.
Indraccolo S; Minuzzo S; Nicoletti L; Cretella E; Simon M; Papakonstantinou G; Hehlmann R; Mion M; Bertorelle R; Roganovic J; Chieco-Bianchi L
Blood; 1999 Oct; 94(7):2424-32. PubMed ID: 10498615
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
51. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
52. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
53. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract][Full Text] [Related]
54. Expression of DNA mismatch repair genes in naevi.
Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer.
Stone JG; Robertson D; Houlston RS
J Clin Pathol; 2001 Jun; 54(6):484-7. PubMed ID: 11376026
[TBL] [Abstract][Full Text] [Related]
56. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
57. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
58. Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer.
V S; Bhagat R; C S P; V R P; Krishnamoorthy L
Genomics; 2014 Oct; 104(4):257-63. PubMed ID: 25192888
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract][Full Text] [Related]
60. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
